What are you looking for today?

Carnell, A. J., Kirk, R., Smith, Matthew, McKenna, S., Lian, L-Y. and Gibson, R. (2013) Inhibition of Humana-Methylacyl CoA Racemase(AMACR): a Target for Prostate Cancer. ChemMedChem, 8. pp. 1643-1647. ISSN 1860-7179

Document

  • [thumbnail of ChemMedChem - 2013 - Carnell - Inhibition of Human ‐Methylacyl CoA Racemase AMACR a Target for Prostate Cancer.pdf]
    ChemMedChem - 2013 - Carnell - Inhibition of Human ‐Methylacyl CoA Racemase AMACR a Target for Prostate Cancer.pdf - Published Version
    Restricted to Registered users only

Abstract

Abstract

The enzyme α-methylacyl CoA racemase (AMACR) is involved in the metabolism of branched-chain fatty acids and has been identified as a promising therapeutic target for prostate cancer. By using the recently available human AMACR from HEK293 kidney cell cultures, we tested a series of new rationally designed inhibitors to determine the structural requirements in the acyl component. An N-methylthiocarbamate (Ki=98 nM), designed to mimic the proposed enzyme-bound enolate, was found to be the most potent AMACR inhibitor reported to date.

Item Type: Article
Depositing User: Matt Smith
URI: https://sure.sunderland.ac.uk/id/eprint/16335

Further Details

More Information

Depositing User

Identifiers

Item ID
16335
Identification Number
ISSN
1860-7179

Users with ORCIDS

ORCID for Matthew Smith

Catalogue record

Date Deposited
09 Aug 2023 13:04
Last Modified
04 Jun 2025 16:06

Contributors

Author
A. J. Carnell
Author
R. Kirk
Author
S. McKenna
Author
L-Y. Lian
Author
R. Gibson

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year